phenyl acetate has been researched along with Epilepsy, Absence in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (53.33) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Posner, E | 1 |
| Abou-Khalil, B; Bautista, J; Bazil, C; Bergen, D; Beydoun, A; Bourgeois, B; Browne, T; Faught, RE; Fischer, JH; French, JA; Gidal, B; Glauser, TA; Harden, CL; Hirtz, D; Kanner, AM; Marks, WJ; Montouris, GD; Nespeca, M; Sachdeo, RC; Schachter, SC; Stern, J; Theodore, WH; Turk, WR; Wilner, A | 1 |
| Fromm, GH | 1 |
| Hosford, DA; Wang, Y | 1 |
| Anhut, H; Ebersole, J; Garofalo, E; LaMoreaux, L; Myers, S; Trudeau, V | 1 |
| Bassilios, N; Deray, G; Khoury, N; Launay-Vacher, V; Rondeau, E; Sraer, JD | 1 |
| Dufour, F; Nalecz, KA; Nalecz, MJ; Nehlig, A | 1 |
| Jesdinsky-Buscher, C; Sutor, AH | 1 |
| Aoki, Y; Mitsutsuka, K; Takahashi, T; Toraiwa, S; Wada, T | 1 |
| Albe-Fessard, D; Kerfriden, M; Kerfriden, P | 1 |
| Amstutz, C; Gasteau, E; Geier, S; Vidart, JN; Vidart, L | 1 |
| Dumon-Radermecker, M | 1 |
| de Biolley, D; Sorel, L | 2 |
| Corbat, F; Scollo-Lavizzari, G | 1 |
3 review(s) available for phenyl acetate and Epilepsy, Absence
| Article | Year |
|---|---|
Absence seizures in children.
Topics: Acetates; Amines; Anticonvulsants; Child; Cyclohexanecarboxylic Acids; Epilepsy, Absence; Ethosuximide; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Triazines; Valproic Acid | 2002 |
Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
Topics: Acetates; Adolescent; Adult; Age Factors; Amines; Antipsychotic Agents; Carbamazepine; Child; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Drug Approval; Epilepsies, Partial; Epilepsy, Absence; Epilepsy, Generalized; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Piracetam; Tiagabine; Topiramate; Triazines; United States; United States Food and Drug Administration; Zonisamide | 2004 |
Gabapentin: discussion.
Topics: Acetates; Amines; Anticonvulsants; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Drugs, Investigational; Epilepsies, Partial; Epilepsy, Absence; Epilepsy, Complex Partial; Gabapentin; gamma-Aminobutyric Acid; Humans; Neural Pathways; Treatment Outcome; Trigeminal Nuclei | 1994 |
1 trial(s) available for phenyl acetate and Epilepsy, Absence
| Article | Year |
|---|---|
Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies.
Topics: Acetates; Amines; Anticonvulsants; Child; Child, Preschool; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Electroencephalography; Epilepsy, Absence; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Treatment Outcome | 1996 |
11 other study(ies) available for phenyl acetate and Epilepsy, Absence
| Article | Year |
|---|---|
Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
Topics: Acetates; Amines; Animals; Anticonvulsants; Cyclohexanecarboxylic Acids; Disease Models, Animal; Drug Evaluation, Preclinical; Electroencephalography; Epilepsy, Absence; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Male; Mice; Nipecotic Acids; Tiagabine; Topiramate; Triazines; Vigabatrin | 1997 |
Gabapentin neurotoxicity in a chronic haemodialysis patient.
Topics: Acetates; Adult; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Epilepsy; Epilepsy, Absence; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Kidney Failure, Chronic; Nervous System; Renal Dialysis | 2001 |
Metabolic approach of absence seizures in a genetic model of absence epilepsy, the GAERS: study of the leucine-glutamate cycle.
Topics: Acetates; Amines; Amino Acids, Branched-Chain; Animals; Brain; Carbon Monoxide; Cells, Cultured; Cerebral Cortex; Cyclohexanecarboxylic Acids; Disease Models, Animal; Energy Metabolism; Epilepsy, Absence; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Glucose; Glutamic Acid; Keto Acids; L-Lactate Dehydrogenase; Leucine; Male; Neurons; Rats; Rats, Mutant Strains; Synaptic Transmission; Synaptic Vesicles; Transaminases | 2001 |
[Blood coagulation changes through dipropyl-acetic-acid (Ergenyl)].
Topics: Acetates; Adolescent; Anticonvulsants; Blood Coagulation; Child; Child, Preschool; Epilepsy, Absence; Epilepsy, Tonic-Clonic; Female; Humans; Male | 1974 |
[Clinical evaluation of sodium dipropylacetate (DPA), a new anti-epileptic drug].
Topics: Acetates; Adolescent; Adult; Anticonvulsants; Child; Encephalitis; Epilepsy; Epilepsy, Absence; Epilepsy, Tonic-Clonic; Female; Humans; Male; Middle Aged; Sodium; Time Factors | 1969 |
[The Toul-ar-C'Hoat experiment: depakine in the treatment of epileptic children. Longitudinal studies of 74 children].
Topics: Acetates; Adolescent; Adult; Anticonvulsants; Child; Child, Institutionalized; Drug Synergism; Electroencephalography; Epilepsy; Epilepsy, Absence; Epilepsy, Tonic-Clonic; France; Humans | 1970 |
[Results obtained with DPA at the Hôpital de Jour for epileptic patients in Créteil].
Topics: Acetates; Adolescent; Adult; Anticonvulsants; Electroencephalography; Epilepsy; Epilepsy, Absence; Epilepsy, Tonic-Clonic; Female; Humans; Male | 1969 |
[Results obtained with Depakine in epilepsy resistant to other therapies. Preliminary note].
Topics: Acetates; Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Epilepsy, Temporal Lobe; Epilepsy, Tonic-Clonic; Female; Humans; Infant; Male; Myoclonus; Phenobarbital | 1969 |
[Experimental and clinical results of a new anti-epileptic: sodium di-n-propyl acetate (DPA) specialized under the marketed name, Depakine. Second study].
Topics: Acetates; Adolescent; Animals; Anticonvulsants; Behavior; Child; Child, Preschool; Electroencephalography; Epilepsy; Epilepsy, Absence; Epilepsy, Temporal Lobe; Epilepsy, Tonic-Clonic; Humans; Infant; Myoclonus; Pentylenetetrazole; Rabbits | 1969 |
[First clinical results of a new anti-epileptic: sodium di-n-propyl acetate (DPA) specialized under the marketed name, Depakine].
Topics: Acetates; Adolescent; Adult; Anticonvulsants; Behavior; Child; Child, Preschool; Electroencephalography; Epilepsy; Epilepsy, Absence; Epilepsy, Temporal Lobe; Epilepsy, Tonic-Clonic; Humans; Infant; Myoclonus | 1969 |
A clinical note on a new antiepileptic 'Depakine'.
Topics: Acetates; Adolescent; Adult; Anticonvulsants; Child; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Epilepsy, Tonic-Clonic; Evaluation Studies as Topic; Female; Gastrointestinal Diseases; Humans; Male; Myoclonus | 1970 |